In NSCLC, silencing of ID1 in radio/chemotherapy-resistant adenocarcinoma cells sensitized adenocarcinoma cells to radiotherapy and chemotherapy [28]. This evidence concerns the gene ID1 and non-small cell lung carcinoma.